Also trades as: PIIIW (NASDAQ) · $vol 0M
PIII NASDAQ
P3 Health Partners Inc.
1W: -9.8%
1M: -32.4%
3M: -38.2%
YTD: +81.7%
1Y: -27.7%
3Y: -91.2%
5Y: -98.7%
$6.36
+0.09 (+1.44%)
Weekly Expected Move ±7.2%
$5
$6
$6
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$1.5B
-2.8% ▼
5Y CAGR: +24.3%
Gross Profit
-$144M
-109.6% ▼
Operating Income
-$270M
+15.7% ▲
Net Income
-$148M
-8.9% ▼
EPS (Diluted)
$-45.26
+16.3% ▲
EBITDA
-$186M
+5.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $637M | $1.0B | $1.3B | $1.5B | $1.5B |
| YoY Growth | +101037.3% | -99.8% | +20.7% | +18.5% | -2.8% |
| Cost of Revenue | $668M | $0 | $0 | $0 | $1.6B |
| Gross Profit | -$31M | $1.0B | $1.3B | $1.5B | -$144M |
| Gross Margin | -4.8% | 100.0% | 100.0% | 100.0% | -9.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $157M | $162M | $126M | $114M | $107M |
| Operating Expenses | $157M | $2.6B | $1.4B | $1.8B | $126M |
| Operating Income | -$188M | -$1.6B | -$168M | -$321M | -$270M |
| Operating Margin | -29.5% | -148.7% | -13.3% | -21.4% | -18.5% |
| Interest Expense | $11M | $11M | $16M | $22M | $55M |
| Income Before Tax | -$204M | -$1.6B | -$184M | -$306M | -$321M |
| Tax Expense | $0 | $2M | $3M | $4M | $2M |
| Net Income | -$156M | -$270M | -$58M | -$136M | -$148M |
| Net Margin | -24.6% | -25.7% | -4.6% | -9.1% | -10.1% |
| EPS (Diluted) | $-188.17 | $-324.84 | $-30.44 | $-54.06 | $-45.26 |
| EBITDA | -$185M | -$1.5B | -$81M | -$198M | -$186M |
| Shares Outstanding | 831577 | 831580 | 2M | 3M | 3M |